What happened
Mere days after enjoying a major stock price pop, Intellia Therapeutics(NASDAQ:NTLA) had another good day on Wednesday. The gene-editing specialist’s shares closed almost 7% higher on news of its latest capital-raising move.
So what
Intellia…
